Antonio Luis
Valero Santiago
Publicaciones en las que colabora con Antonio Luis Valero Santiago (22)
2024
-
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32
-
Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort
Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 3, pp. 192-195
-
The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria
Respiratory Medicine, Vol. 226
2023
-
ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482
-
Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations
Pulmonology
-
Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288
-
Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231
-
Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti–IL-5 Biologics: A Real-Life Study
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 1, pp. 37-44
-
Lung Function Abnormalities and Their Correlation With Clinical Characteristics and Inflammatory Markers in Adult Asthma
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 294-296
-
Reply to “Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies”
Journal of Investigational Allergology and Clinical Immunology
2022
-
Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 3, pp. 863-866.e1
-
Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis
Immunotherapy, Vol. 14, Núm. 9, pp. 683-694
-
How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?
Clinical and Translational Allergy, Vol. 12, Núm. 8
2021
-
Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort
Clinical and Translational Allergy, Vol. 11, Núm. 1
-
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 1, pp. 487-489.e1
-
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)
Drugs
-
REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study
Drugs, Vol. 81, Núm. 15, pp. 1763-1774
2018
-
Safety and Quality Recommendations in Allergy Medicine (Spanish acronym, RESCAL)
Journal of investigational allergology & clinical immunology, Vol. 28, pp. 1-39
-
The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up
Archivos de Bronconeumologia, Vol. 54, Núm. 7, pp. 378-385
2017
-
Quality indicators of asthma care derived from the spanish guidelines for asthma management (GEMA 4.0): A multidisciplinary team report
Journal of Investigational Allergology and Clinical Immunology